Fresenius Kabi NY aseptic plant upgraded by USFDA
A Fresenius Kabi plant in New York has been upgraded, and up to five new products could receive FDA approval, almost three years after receiving a warning letter.
A Fresenius Kabi plant in New York has been upgraded, and up to five new products could receive FDA approval, almost three years after receiving a warning letter.
A bipartisan bill that aims to expedite the release of new treatments by modernizing clinical trials is in the works.
The value of the Swiss franc fluctuated today after the country’s central bank abandoned its minimum Euro exchange rate in a shock move that saw shares in Roche, Novartis, Actelion, SGS and Lonza fall.
AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.
As the second-largest central labs provider in the world, Quintiles is looking at the LabCorp acquisition of the world’s leading central labs provider Covance as a way to potentially nab more market share.
CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the site perks up in the near future.